Biosimilars Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-1290 | Report Format : | Status : Upcoming |

Abstract

Global Biosimilars Market: Overview

Biosimilar is a biopharmaceutical product which is similar to the previous or the original existing product that is manufactured by a company. The biosimilar also has alternative names such as subsequent entry biologic or follow-on biologic. When the patent of the original product expires biosimilars can be manufactured which are approved officially. When the patent expires of an approved recombinant drug any other biotech company can generate and market these biologics, thus the name biosimilars.

Global Biosimilars Market: Segmentation

The global biosimilars market is segmented into its product, manufacturing type and application. Based on the product, the market is segregated into recombinant non-glycosylated proteins, recombinant peptides, and recombinant glycosylated proteins. Further, the recombinant non-glycosylated proteins are sub-segmented into granulocyte colony-stimulating factor, interferons, insulin, and recombinant human growth hormones. The recombinant glycosylated proteins segment is sub-segmented into urofollitropin, erythropoietin, and monoclonal antibodies. the insulin and granulocyte colony-stimulating factor segment is sub-segmented into calcitonin and glucagon. On the basis of the manufacturing type, the market is categorized into contract manufacturing organizations and in-house manufacturing. On the basis of application, the market is divided into blood disorders, growth hormone deficiency, oncology, chronic & autoimmune diseases, infectious diseases, and others.

Global Biosimilars Market: Growth Factors

The major factor that contributed to the biosimilars market growth is the emergence of the biologic products that are off-patent. These drugs are very cost-effective thus making its demand to increase substantially. In the coming years, this demand for the biosimilars is going to increase. The increasing rate of the diseases across the globe has also helped in contributing towards the market growth. The manufacturers of the biologic drug have started to take initiatives in making innovative strategies in order to develop the biosimilars market. Even though the market is in a phase where it is flourishing there are some restraining factors that are affecting the market growth. The factors such as lengthy clinical trials which are required from the regulatory bodies for approval and the production of biosimilars require complex infrastructure are affecting the market growth.

Global Biosimilars Market: Regional Analysis

The biosimilars market is geographically segmented into North America, Europe, Asia-Pacific, and Rest of the World. The region that is leading the biosimilars market is Europe and it accounts for the largest share in the global market. The factors that have attributed to this growth are Omni trope, bino crits, and lenograstim. Additionally, the strict regulatory framework and the increasing pipeline products estimate to contribute towards the growth of the European biosimilars market. There are opportunities increasing in the regions such as Asia Pacific region. As per the study, the Asia-Pacific region will have a progressive growth rate in the coming years. The stringent protocols in the US are hampering the biosimilars market in the North American region.

Global Biosimilars Market: Competitive Players

The key market players in the biosimilars market include Pfizer Inc., Teva Pharmaceuticals Industries Ltd., Biocon Ltd., F. Hoffmann-La Roche Ltd., Samsung Bioepis, Sandoz International GmbH, Amgen Inc., Dr. Reddy’s Laboratories Ltd. and Celltrion, Inc.

Global Biosimilars Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Pain Management Therapeutics Market by Drug Class (Anesthetics, NSAIDS, Anticonvulsants, Antidepressants, Anti-migraine agents, Non-narcotic Analgesics, and Opioids (Tramadol, Oxycodone, Hydrocodone, and Others)); by Indication (Neuropathic Pain, Arthritic Pain, Cancer Pain, Post-operative Pain, Chronic Back Pain, Fibromyalgia, and Migraine), and by Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 130 | Report Code: ZMR-3373 | Report Format:

The report covers forecast and analysis for the pain management therapeutics market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pa...Read More

Healthcare Regulatory Affairs Outsourcing Market by Services (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs) and by End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food and Beverage Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3369 | Report Format:

The report covers forecast and analysis for the healthcare regulatory affairs outsourcing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints fo...Read More

Thrombosis Drug Market by Drug Class (Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor), by Indications (Pulmonary Embolism, Atrial Fibrillation, and Deep Vein Thrombosis), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3363 | Report Format:

The report covers forecast and analysis for the thrombosis drug market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the thrombosis drug market along...Read More

Artificial Intelligence in Diabetes Management Market by Device (Glucose Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices, and Other Devices) and by Technique Type (Case-based Reasoning and Intelligent Data Analysis): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 160 | Report Code: ZMR-3361 | Report Format:

The report covers forecast and analysis for the artificial intelligence in diabetes management market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.